FRANKLIN LAKES, N.J., Jan. 26, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its new BD Institute for ...

As the market for GLP-1 injections continues to grow, BD aims to ride that wave by providing drugmakers with its prefilled syringes. Biologic medications—including those blockbusters for diabetes and ...

FRANKLIN LAKES, N.J. & SAN DIEGO--(BUSINESS WIRE)-- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation ...

FRANKLIN LAKES, N.J., Sept. 22, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a pharmacy automation partnership with ...

Yesterday, Becton, Dickinson and Company BDX, popularly known as BD, announced a collaboration with ChemoGLO, a notable name in hazardous drug detection and decontamination. The partnership is aimed ...

BD announced Aug. 25 the promotion of two executives to segment presidents. They will also serve on the Franklin Lakes-based medical tech provider’s executive leadership team. Michael “Mike” Garrison ...

FRANKLIN LAKES, N.J., March 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, today issued the following statement regarding the March 19, ...

BD announced the general release of its Pyxis ES System, a scalable, web–accessible platform designed to improve medication management. The system is comprised of the Pyxis Enterprise Server, Pyxis ...

BD demonstrated how its portfolio supports the evolving needs of pharmaceutical and biotechnology companies developing biologics – GLP-1 therapies, vaccines, and acute care medicines – as the industry ...

Becton, Dickinson and Co. plans to invest more than $35 million to expand a prefilled flush syringe manufacturing facility in Nebraska to better meet growing demand from U.S. hospitals and health care ...